Leaflet AVAGLIM 8mg / 4mg film-coated tablets
Indicated for: type 2 diabetes mellitus
Route of administration: oral
Substance: rosiglitazone + glimepiride (thiazolidinedione antidiabetic + sulfonylurea antidiabetic)
ATC: A10BD04 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs)
This medicine may lower blood sugar.
Use during pregnancy only on medical advice.
Rosiglitazone+glimepiride is a combination medication used in the treatment of type 2 diabetes mellitus. Rosiglitazone increases insulin sensitivity in cells, while glimepiride, a sulfonylurea derivative, stimulates insulin secretion from the pancreas.
This combination is taken orally, usually once daily, and is indicated for patients who fail to control their blood sugar levels through diet, exercise, or other antidiabetic medications. It is effective in lowering blood glucose levels and preventing diabetes-related complications.
Common side effects include hypoglycemia, weight gain, nausea, and fluid retention. In rare cases, severe adverse reactions such as heart failure or allergic reactions may occur. Regular monitoring of blood glucose levels and cardiac function is essential.
Rosiglitazone+glimepiride is an effective therapeutic option for patients with type 2 diabetes, offering improved glycemic control through complementary mechanisms of action.
General data about AVAGLIM 8mg / 4mg
- Substance: rosiglitazone + glimepiride
- Date of latest medicines list: 01-07-2013
- Product code: W51440004
- Concentration: 8mg / 4mg
- Pharmaceutical form: film-coated tablets
- Quantity: 84
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for rosiglitazone + glimepiride
- 4mg/4mg
- 8mg/4mg